FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to preventive vaccination. Disclosed is a vaccine composition containing one or more antigen and an adjuvant containing oleic acid and monoolein to be used for intranasal vaccination of a patient.
EFFECT: using the invention enables preventing developing of the said vaccine composition side effect - Bell's palsy.
20 cl, 15 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
VACCINE COMPOSITION FOR NON-IMMUNISED INDIVIDUALS | 2013 |
|
RU2661407C2 |
NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS | 2013 |
|
RU2661408C2 |
COMPOSITIONS FOR TREATING AND PREVENTING COMPLEX OF RESPIRATORY DISEASES IN DOGS | 2012 |
|
RU2553222C2 |
ADJUVANT COMPOSITION, CONTAINING NANOPARTICLES OF POLY-GAMMA-GLUTAMIC ACID-CHITOSAN | 2010 |
|
RU2558794C2 |
FUNCTIONALLY RECONSTRUCTED ADJUVANT-CONTAINING VIRUS MEMBRANES | 2004 |
|
RU2348428C2 |
MAIN FATTY ACID ETHERS AND THEIR APPLICATION AS ANTI-INFLAMMATION OR IMMUNOMODULATORY MEDICATIONS | 2003 |
|
RU2337093C2 |
IMMUNOGENIC COMPOSITIONS OF Bordetella bronchiseptica | 2012 |
|
RU2554480C2 |
ADJUVANT COMPOSITION CONTAINING ALUMINUM, AND CONTAINING ITS VACCINE COMPOSITION | 2016 |
|
RU2721417C2 |
FOOT-AND-MOUTH DISEASE VACCINE | 2016 |
|
RU2698305C2 |
Authors
Dates
2016-07-20—Published
2011-09-30—Filed